Symbiotec Pharmalab’s Rs 1,757 crore IPO opens August 24, with a Rs 938–988 price band and 41% grey-market premium. The issue combines fresh shares and an OFS, while proceeds will partly repay debt. Its specialised API manufacturing, regulatory approvals and biotechnology capabilities offer investors exposure to India’s pharmaceutical manufacturing growth.
Symbiotec Pharmalab’s Rs 1,757 crore IPO opens August 24, with a Rs 938–988 price band and 41% grey-market premium. The issue combines fresh shares and an OFS, while proceeds will partly repay debt. Its specialised API manufacturing, regulatory approvals and biotechnology capabilities offer investors exposure to India’s pharmaceutical manufacturing growth.
<iframe src="https://hindustansphere.com/embed/cluster/7fa701bc13f506cce5ea7d2a688fe3a2178ac500" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Symbiotec Pharmalab IPO opens today: GMP signals 41% upside — Should you subscribe?"></iframe>
